Macy's, Inc. (M)

NYQ – Real Time Price. Currency in USD

18.52

-0.17 (-0.91%)

At close: May 12, 2026, 4:00 PM EDT

18.47

-0.05 (-0.25%)

Pre-market: May 13, 2026, 8:20 AM EDT

11.05.2026

Macy's (M) Stock Declines While Market Improves: Some Information for Investors

In the closing of the recent trading day, Macy's (M) stood at $18.66, denoting a -4.21% move from the preceding trading day.

11.05.2026

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

A Technically Simple Restart with Strong Economics SAN BERNARDINO, CA / ACCESS Newswire / May 11, 2026 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) (Dateline or the Company) is pleased to present the results of the Bankable Feasibility Study (BFS) for the 100%-owned Colosseum Gold and Rare Earth Element (REE) Project in San Bernardino County, California. The BFS demonstrates a robust gold development, generating significant margins.

06.05.2026

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

NEW YORK--(BUSINESS WIRE)--Macy's announces its latest designer collaboration with its On 34th brand, designed with Emmy Award–winning costume designer, Molly Rogers.

04.05.2026

Why Macy's (M) Dipped More Than Broader Market Today

Macy's (M) closed at $19.19 in the latest trading session, marking a -2.56% move from the prior day.

30.04.2026

Avolon Q1 Net Income up 32% to US$191 Million

DUBLIN--(BUSINESS WIRE)--Avolon, a leading global aviation finance company, announces results for the first quarter (‘Q1') of 2026. Income Statement (US$M) Q1 2026 Q1 2025 US$ Change % Change Lease Revenue 762 683 +79 +12% Operating Cashflow 540 365 +175 +48% Net Income 191 145 +46 +32% Balance Sheet (US$M) Q1 2026 FY 2025 US$ Change % Change Total Available Liquidity 11,288 10,659 +629 +6% Total Assets 34,702 34,418 +284 +1% Unsecured Debt / Total Debt 79% 77% +2ppts N/A 2026 FIRST QUARTER HIG.

29.04.2026

AstraZeneca results: Q1 2026

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca: Revenue and EPS summary Q1 2026 % Change $m Actual CER1 - Product Sales 14,386 12 7 - Alliance Revenue 825 29 26 Product Revenue 15,211 13 8 Collaboration Revenue 77 4 - Total Revenue 15,288 13 8 Reported EPS ($) 1.99 6 8 Core2 EPS ($) 2.58 4 5 Key performance elements for Q1 2026 (Growth numbers at constant exchange rates) Total Revenue up 8% to $15,288m, driven by double‑digit growth in Oncology and Rare Disease Core Operating profit incre.

29.04.2026

Ecora Royalties PLC Announces Q1 2026 Trading Update

LONDON / ACCESS Newswire / April 29, 2026 / Ecora (LSE:ECOR)(TSX:ECOR)(OTCQX:ECRAF) issues the following trading update for the period 1 January to 31 March 2026. Marc Bishop Lafleche, Chief Executive Officer of Ecora, commented: "Q1 was a solid start to the year with total portfolio contribution up 105% v Q1 2025, primarily driven by the continued performance of the base metals portfolio which was up 152% v Q1 2025.

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

NEW YORK--(BUSINESS WIRE)--Macy's announces its latest designer collaboration with its On 34th brand, designed with Emmy Award–winning costume designer, Molly Rogers.

30.04.2026

Avolon Q1 Net Income up 32% to US$191 Million

29.04.2026

Macy's, Inc. (M)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Macy's, Inc. (M)

Macy's (M) Stock Declines While Market Improves: Some Information for Investors

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Why Macy's (M) Dipped More Than Broader Market Today

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Ecora Royalties PLC Announces Q1 2026 Trading Update

Videos

Press releases

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Macy's (M) Stock Declines While Market Improves: Some Information for Investors

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Why Macy's (M) Dipped More Than Broader Market Today

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Ecora Royalties PLC Announces Q1 2026 Trading Update

Videos

Press releases

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Search stocks

Macy's, Inc. (M)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Macy's, Inc. (M)

Macy's (M) Stock Declines While Market Improves: Some Information for Investors

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Why Macy's (M) Dipped More Than Broader Market Today

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Ecora Royalties PLC Announces Q1 2026 Trading Update

Videos

Press releases

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Macy's (M) Stock Declines While Market Improves: Some Information for Investors

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Why Macy's (M) Dipped More Than Broader Market Today

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026

Ecora Royalties PLC Announces Q1 2026 Trading Update

Videos

Press releases

Colosseum Bankable Feasibility Study Confirms High Margin Gold Project

Macy's and Molly Rogers Celebrate the Spirit of NYC in New On 34th Collaboration

Avolon Q1 Net Income up 32% to US$191 Million

AstraZeneca results: Q1 2026